Low-Dose Isotretinoin for Effective Rosacea Management
The article discusses the ideal candidates for low-dose isotretinoin (LDI) therapy in treating moderate to severe rosacea, particularly those who have not responded to conventional treatments. Suitable patients typically range from 30 to 60 years …